Emerging Technologies for Assessing HER2 Amplification-Reference-Cited by-同舟云学术

Emerging Technologies for Assessing HER2 Amplification

Published:2009-10-01 Issue:4 Volume:132 Page:539-548
ISSN:1943-7722
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:

Author:

Penault-Llorca Frédérique¹,Bilous Michael²,Dowsett Mitch³,Hanna Wedad⁴,Osamura Robert Yoshiyuki⁵,Rüschoff Josef⁶,van de Vijver Marc⁷

Affiliation:

1. Department of Pathology, Centre Jean Perrin and EA 4233, University of Auvergne, Clermont-Ferrand, France

2. Institute of Clinical Pathology and Medical Research, Westmead Hospital, Westmead, Australia

3. Department of Biochemistry, the Royal Marsden Hospital, London, England

4. Sunnybrook and Women’s College Health Science Centre, Toronto, Canada

5. Department of Pathology, Tokai University School of Medicine, Kanagawa, Japan

6. Institute of Pathology, Klinikum Kassel, Kassel, Germany

7. Department of Pathology, the Netherlands Cancer Institute, Amsterdam, the Netherlands

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/132/4/539/24987365/ajcpath132-0539.pdf

Reference72 articles.

1. HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues;Owens;Clin Breast Cancer,2004

2. Incidence and implications of HER2 and hormonal receptor overexpression in newly diagnosed metastatic breast cancer (MBC) [abstract];Penault-Llorca;J Clin Oncol,2005

3. Targeted therapy in breast cancer: the HER-2/neu gene and protein;Ross;Mol Cell Proteomics,2004

4. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

5. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer;Slamon;Science,1989

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comprehensive Review on the Role of Human Epidermal Growth Factor Receptor 2 (HER2) as a Biomarker in Extra-Mammary and Extra-Gastric Cancers;Onco;2023-05-26

2. Research progress of antibody-drug conjugates therapy for HER2-low expressing gastric cancer;Translational Oncology;2023-03

3. Human Epidermal Growth Factor Receptor 2–Targeting Approaches for Colorectal Cancer: Clinical Implications of Novel Treatments and Future Therapeutic Avenues;JCO Oncology Practice;2022-08

4. Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: An update;GENES DIS;2022

5. Predictive Biomarkers in Breast Cancer: ER, PR, and HER-2/NEU;Handbook of Practical Immunohistochemistry;2022